Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 Next >
5 things to know before the stock market opens
Tags Economy Paramount Global Business News
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags US Top News and Analysis China Economy Pharmaceuticals
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Companies Business Health & Science
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Novo Nordisk A/S Eli Lilly and Co Breaking News: Markets
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Novo Nordisk A/S Eli Lilly and Co Biotech and Pharmaceuticals
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Companies Health care industry Business
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags World Markets Europe Markets Prices
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Employee benefits Employee healthcare benefits Health care industry
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Biotechnology Biotech and Pharmaceuticals Business News
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags U/S/ Markets Apple Inc Stock markets
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Chugai Pharmaceutical Co Ltd Stock markets Novo Nordisk A/S
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Breaking News: Technology Technology Internet
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Biotech and Pharmaceuticals Uber Technologies Inc Eli Lilly and Co
From CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
Tags Business News Novo Nordisk A/S Europe News
From CNBC.com News
Hims & Hers Health adds compounded GLP-1 injections to weight loss program
Tags Hims & Hers Health Inc Technology Health care industry
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Biotechnology Biotech and Pharmaceuticals Carmot Therapeutics Inc
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Health care industry Healthy Returns Health & Science
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Health care industry Business Companies
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Health & Science Health care industry Healthy Returns
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Business Health care industry Zealand Pharma A/S
From CNBC.com News
Amgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide
Tags Business News Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Amgen scraps experimental weight loss pill, moves forward with injection
Tags Health care industry Business Companies
From CNBC.com News
Novo Nordisk beats profit estimates as sales of weight loss drug Wegovy more than double
Tags Earnings Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
Tags Business GSK plc Health care industry
From CNBC.com News
Senate launches investigation into high prices of Ozempic and Wegovy in the U.S.
Tags Congress Politics Health care industry
From CNBC.com News
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
Tags Health care industry Pharmaceuticals Health & Science
From CNBC.com News
Most people on weight loss drugs are spending less on restaurants and takeout, survey says
Tags Chipotle Mexican Grill Inc US: News Diageo PLC
From CNBC.com News
Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
Tags Novo Nordisk A/S US: News Eli Lilly and Co
From CNBC.com News
Eli Lilly’s Zepbound shows promise as a sleep apnea treatment in late-stage trials
Tags Business News Science Biotech and Pharmaceuticals
From CNBC.com News
EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
Tags Companies Breaking news Business
From CNBC.com News
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.